Sofinnova Partners portfolio

Sofinnova Partners (Venture capital) is known to hold 127 companies, 48 of them startups. 18 of them are hiring now, with 930 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 10 venture rounds in 12 months, raising $672.7M. Most of them work in Industrial Biotechnology, Biologics & Biosimilars, Immunology & Inflammation Therapeutics.

Source: Alion Venture capital Oct 5, 2026
Investments
127
48 of them startups
Hiring now
18
930 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
10
$672.7M raised
Exits
16

Companies Sofinnova Partners has invested in

HighLife Medical Cardiovascular Devices Venture round $90M · this month portfolio pageSep 25
Mironid Series B $43.1M · 1 mo ago portfolio pageSep 25
TISSIUM Plastics & Polymers · France Venture round $68M · 3 mo ago portfolio pageOct 2
Ingenix AI for Science Seed $14M · 4 mo ago lead portfolio page, round in the pressJun 3
GenSight Biologics Cell & Gene Therapy Venture round $1.8M · 6 mo ago portfolio pageSep 25
May Health France Venture round $11.7M · 6 mo ago portfolio pageSep 25
Mediar Therapeutics Series B $76M · 8 mo ago portfolio pageSep 25
AAVantgarde Series B $141M · 10 mo ago 1 role portfolio pageSep 25
Hemab Venture round $157M · 11 mo ago portfolio pageSep 25
Elevara Medicines Immunology & Inflammation Therapeutics Series A $70M · 11 mo ago portfolio pageSep 25
Arzeda Synthetic Biology Venture round $4.5M · 13 mo ago 2 roles portfolio pageSep 25
SafeHeal Series C $37.8M · 17 mo ago portfolio pageOct 2
Latent Labs United Kingdom Venture round $50M · 19 mo ago 7 roles portfolio pageSep 25
Bioptimus Foundation Models · France Venture round $41M · 20 mo ago 6 roles portfolio pageSep 25
Elicit Plant Food Technology Series B $48.6M · 22 mo ago portfolio pageSep 25
Noema Pharma Prescription Drugs · Switzerland Series B · 22 mo ago 1 role portfolio page, round in the pressNov 12, 2024
Genespire Series B $50.3M · 2 yr ago lead portfolio page, round in the pressSep 25, 2024
Novameat Vegan Food Series A $18.8M · 2 yr ago portfolio pageSep 25
Cure51 Drug Discovery AI · France Seed $16.2M · 2 yr ago portfolio pageSep 25
Mainstay Medical Neurotech & Neuromodulation Venture round $125M · 2 yr ago 6 roles portfolio pageSep 25
CorWave Cardiovascular Devices · France Series C $65.9M · 3 yr ago 3 roles portfolio pageSep 25
Alia therapeutics Cell & Gene Therapy Seed $4.8M · 3 yr ago lead portfolio page, round in the pressApr 17, 2023
Deepc Medical AI Series A $13M · 3 yr ago portfolio pageSep 25
BioCorteX Drug Discovery Venture round $5M · 3 yr ago lead portfolio page, round in the pressMar 27, 2023
Chroma Bio, Inc. United States Venture round $135M · 3 yr ago portfolio pageSep 25
EnginZyme Industrial Biotechnology Series B $22.7M · 3 yr ago lead portfolio page, round in the pressApr 22, 2020
Inspirna Oncology Therapeutics · United States Venture round $55.1M · 4 yr ago portfolio pageSep 25
LimFlow France Series D $40M · 4 yr ago portfolio pageSep 25
Prometheus Materials United States Venture round $4.1M · 4 yr ago portfolio pageSep 25
Synthace Higher Education Series C $35M · 4 yr ago portfolio pageOct 2
Veronapharma Venture round $200.2M · 6 yr ago portfolio pageOct 2
CorVent Medical Respiratory & Sleep Devices · United States Seed $4.5M · 6 yr ago portfolio pageSep 25
Pi-Cardia Cardiovascular Devices Venture round $27M · 6 yr ago lead portfolio page, round in the pressApr 19, 2020
P2Science Venture round $15.6M · 6 yr ago portfolio pageSep 25
Hookipapharma Venture round $37.4M · 7 yr ago portfolio pageSep 25
Shockwave Medical United States Venture round $15M · 7 yr ago portfolio pageOct 2
MaxCyte Cell & Gene Therapy · United States Venture round $760k · 10 yr ago 5 roles portfolio pageSep 25
Medtronic Cardiovascular Devices · Ireland 878 roles portfolio pageSep 25
Ascendis Pharma Prescription Drugs · Denmark 22 roles portfolio pageSep 25
Tenpoint Therapeutics Prescription Drugs · United States 9 roles portfolio pageOct 2
Galvanize Therapeutics® Inc Property & Casualty Insurance 8 roles portfolio pageSep 25
DBV Technologies Biologics & Biosimilars 6 roles portfolio pageSep 25
Avantium Chemical Manufacturing · Netherlands 4 roles portfolio pageSep 25
DNA Script Synthetic Biology · France 2 roles portfolio pageSep 25
GlycoEra Switzerland 2 roles portfolio pageSep 25
iOmx Therapeutics Cell & Gene Therapy 2 roles portfolio pageSep 25
90Phutzac Sports Media portfolio pageSep 25
Abivax | Immunology & Inflammation Therapeutics · France portfolio pageSep 25
AFYREN Bioenergy · France portfolio pageSep 25
Bionyra Pharma Biologics & Biosimilars portfolio pageSep 25
Biosyntia Denmark portfolio pageSep 25
Biotalys Crop Protection portfolio pageSep 25
Calliditas Therapeutics AB Biologics & Biosimilars portfolio pageSep 25
Cometbio Microbiome portfolio pageSep 25
DISCO Pharmaceuticals GmbH Oncology Therapeutics portfolio pageSep 25
DMC Biotechnologies Brewing & Beer portfolio pageSep 25
GFBiochemicals SAS Chemical Engineering portfolio pageSep 25
HeartRecovery Job Boards & Aggregators portfolio pageSep 25
Inventiva Cardiometabolic Therapeutics portfolio pageSep 25
Kiro Medical AI · France portfolio pageSep 25
Meiogenix Synthetic Biology portfolio pageSep 25
Metgen Industrial Biotechnology portfolio pageSep 25
Micropep Crop Protection portfolio pageSep 25
microphyt Food Biotechnology portfolio pageSep 25
Moon Surgical Surgical Instruments & Devices · France portfolio pageSep 25
Mozart Tx Biologics & Biosimilars portfolio pageSep 25
Muna Therapeutics Neurology & CNS Therapeutics portfolio pageSep 25
12

Focus

Markets
Industrial Biotechnology4%
Biologics & Biosimilars4%
Immunology & Inflammation Therapeutics3%
Cell & Gene Therapy3%
Synthetic Biology3%
Cardiovascular Devices3%
Drug Discovery2%
AI for Science2%
Where its companies are
France9%
United States6%
Denmark2%
Switzerland2%
Netherlands1%
Ireland1%
United Kingdom1%
Stage of its companies
Venture, series not stated51%
Series B19%
Pre-seed & seed11%
Series C and later11%
Series A8%

Questions about Sofinnova Partners

How many companies has Sofinnova Partners invested in?

Sofinnova Partners is known to hold 127 companies: 48 startups, and 16 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Sofinnova Partners investing now?

Yes: in the last 12 months 1 rounds in the press named Sofinnova Partners (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does Sofinnova Partners invest in?

The markets of the companies Sofinnova Partners holds: Industrial Biotechnology (4%), Biologics & Biosimilars (4%), Immunology & Inflammation Therapeutics (3%), Cell & Gene Therapy (3%), Synthetic Biology (3%).

Which Sofinnova Partners portfolio companies are hiring?

18 companies Sofinnova Partners holds are hiring now, with 930 open roles listed on this page.

Who does Sofinnova Partners invest alongside?

The investors that hold the most companies together with Sofinnova Partners: M Ventures, Kurma Partners, Sofinnova Investments, Aisling Capital, RA Capital Management.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 4; 8 rounds in the press that name it

Sofinnova Partners portfolio: 127 known companies. Alion, Oct 5, 2026. https://alion.io/company/sofinnova-partners/portfolio

Licence: CC BY-SA 4.0JSON